In Vitro Activity of Xanthorrhizol Isolated from the Rhizome of Javanese Turmeric (Curcuma xanthorrhiza Roxb.) Against Candida albicans Biofilms

The purpose of this study was to investigate the activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. on Candida albicans biofilms at adherent, intermediate, and mature phase of growth. C. albicans biofilms were formed in flat‐bottom 96‐well microtiter plates. The biofilms of C. albicans at different phases of development were exposed to xanthorrhizol at different concentrations (0.5 µg/mL ‐ 256 µg/mL) for 24 h. The metabolic activity of cells within the biofilms was quantified using the XTT reduction assay. Sessile minimum inhibitory concentrations (SMICs) were determined at 50% and 80% reduction in the biofilm OD490 compared to the control wells. The SMIC50 and SMIC80 of xanthorrhizol against 18 C. albicans biofilms were 4 – 16 µg/mL and 8 – 32 µg/mL, respectively. The results demonstrated that the activity of xanthorrhizol in reducing C. albicans biofilms OD490 was dependent on the concentration and the phase of growth of biofilm. Xanthorrhizol at concentration of 8 µg/mL completely reduced in biofilm referring to XTT‐colorimetric readings at adherent phase, whereas 32 µg/mL of xanthorrhizol reduced 87.95% and 67.48 % of biofilm referring to XTT‐colorimetric readings at intermediate and mature phases, respectively. Xanthorrhizol displayed potent activity against C. albicans biofilms in vitro and therefore might have potential therapeutic implication for biofilm‐associated candidal infections. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  Jae-Kwan Hwang,et al.  In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms. , 2011, Medical mycology.

[2]  J. Lopez-Ribot,et al.  A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing , 2008, Nature Protocols.

[3]  Jae-Kwan Hwang,et al.  In Vitro antimycotic activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. against opportunistic filamentous fungi , 2007, Phytotherapy research : PTR.

[4]  M. Fan,et al.  In vitro activity of eugenol against Candida albicans biofilms , 2007, Mycopathologia.

[5]  Y. Rukayadi,et al.  In vitro anti‐Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb , 2007, Letters in applied microbiology.

[6]  V. Pruthi,et al.  Prevention of Candida albicans biofilm by plant oils , 2007, Mycopathologia.

[7]  Gordon Ramage,et al.  Candida biofilms on implanted biomaterials: a clinically significant problem. , 2006, FEMS yeast research.

[8]  Jae-Kwan Hwang,et al.  Effect of coating the wells of a polystyrene microtiter plate with xanthorrhizol on the biofilm formation of Streptococcus mutans , 2006, Journal of basic microbiology.

[9]  Jae-Kwan Hwang,et al.  In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. , 2006, The Journal of antimicrobial chemotherapy.

[10]  Y. Rukayadi,et al.  In vitro activity of xanthorrhizol against Streptococcus mutans biofilms , 2006, Letters in applied microbiology.

[11]  Jae-Kwan Hwang,et al.  Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia , 2005, Journal of neuroscience research.

[12]  A. Aboussekhra,et al.  Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. , 2005, Oral microbiology and immunology.

[13]  Seungwon Shin,et al.  Anti‐Candida effects of estragole in combination with ketoconazole or amphotericin B , 2004, Phytotherapy research : PTR.

[14]  J. Eddins,et al.  Fungal biofilms and drug resistance. , 2004 .

[15]  J. A. Lombardi,et al.  Antifungal constituents of Clytostoma ramentaceum and Mansoa hirsuta , 2004, Phytotherapy research : PTR.

[16]  J. Trouillas,et al.  Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. , 2004, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[17]  Jae-Kwan Hwang,et al.  Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. , 2004, Toxicology and applied pharmacology.

[18]  D. Leaman,et al.  Inhibition of human pathogenic fungi by members of Zingiberaceae used by the Kenyah (Indonesian Borneo). , 2003, Journal of ethnopharmacology.

[19]  L. J. Douglas,et al.  Candida biofilms and their role in infection. , 2003, Trends in microbiology.

[20]  J. Graybill,et al.  In Vitro Activity of Caspofungin against Candida albicans Biofilms , 2002, Antimicrobial Agents and Chemotherapy.

[21]  C. Kumamoto Candida biofilms. , 2002, Current opinion in microbiology.

[22]  Mahmoud A. Ghannoum,et al.  Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.

[23]  B. Wickes,et al.  Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms , 2001, Antimicrobial Agents and Chemotherapy.

[24]  G. Arras,et al.  Fungitoxic activity of 12 essential oils against four postharvest citrus pathogens: chemical analysis of thymus capitatus oil and its effect in subatmospheric pressure conditions. , 2001, Journal of food protection.

[25]  Y. Pyun,et al.  Antibacterial activity of xanthorrhizol from Curcuma xanthorrhiza against oral pathogens. , 2000, Fitoterapia.

[26]  Y. Pyun,et al.  Xanthorrhizol: a potential antibacterial agent from Curcuma xanthorrhiza against Streptococcus mutans. , 2000, Planta medica.

[27]  J. Crump,et al.  Intravascular Catheter-Associated Infections , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[28]  E. Veerman,et al.  Amphotericin B- and Fluconazole-ResistantCandida spp., Aspergillus fumigatus, and Other Newly Emerging Pathogenic Fungi Are Susceptible to Basic Antifungal Peptides , 1999, Antimicrobial Agents and Chemotherapy.

[29]  S. Teraguchi,et al.  Inhibition of Hyphal Growth of Azole-Resistant Strains of Candida albicans by Triazole Antifungal Agents in the Presence of Lactoferrin-Related Compounds , 1998, Antimicrobial Agents and Chemotherapy.

[30]  M. Ghannoum,et al.  Comparison of a 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Colorimetric Method with the Standardized National Committee for Clinical Laboratory Standards Method of Testing Clinical Yeast Isolates for Susceptibility to Antifungal Agents , 1998, Journal of Clinical Microbiology.

[31]  K. Hostettmann,et al.  Antiviral activity of African medicinal plants. , 1994, Journal of ethnopharmacology.